[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
April 17, 1967

Phototoxic Reactions Induced by High Doses of Chlorpromazine and Thioridazine

Author Affiliations

From the Provincial Mental Health Services of British Columbia, Canada (Dr. Satanove) and the Department of (Physical) Chemistry, University of British Columbia, Vancouver (Mr. McIntosh).

JAMA. 1967;200(3):209-212. doi:10.1001/jama.1967.03120160075010

Phototoxic reactions to thioridazine hydrochloride appear to be induced by visible light above 4,100 Angstroms as well as by ultraviolet light. Special sunscreen preparations are required to protect against these higher wavelengths of light. The critical dosage level of chlorpromazine hydrochloride required to produce a phototoxic reaction appears to be approximately 600 mg per day, while that of thioridazine hydrochloride is between 400 and 600 mg per day. It is postulated that deposition of pigment in the retina observed in patients receiving high doses of thioridazine hydrochloride (1,800 mg or higher) was due to a phototoxic reaction induced by visible light.

Greiner, A.C., and Berry, K.:  Skin Pigmentation and Corneal and Lens Opacities With Prolonged Chlorpromazine Therapy ,  Canad Med Assoc J 90:663-665 ( (March) ) 1964.
Greiner, A.C., and Nicolson, G.A.:  Pigment Deposit in Viscera Associated With Prolonged Chlorpromazine Therapy ,  Canad Med Assoc J 91:627-631 ( (Sept) ) 1964.
Satanove, A.:  Pigmentation Due to Phenothiazines in High and Prolonged Dosage ,  JAMA 191:263-268 ( (Jan 25) ) 1965.Crossref
Siddall, J.R.:  Ocular Toxic Changes Associated With Chlorpromazine and Thioridazine ,  Canad J Ophthal 1:190, 1966.
Perry, T.L., et al:  7-Hydroxychlorpromazine: Potential Toxic Drug Metabolite in Psychiatric Patients ,  Science 146:81-89 ( (Oct 2) ) 1964.Crossref
Hagopian, V.; Stratton, D.B.; Busiek, R.D.:  Five Cases of Pigmentary Retinopathy Associated With Thioridazine Administration ,  Amer J Psychiat 123:97-100 ( (July 1) ) 1966.
Weekley, R.D., et al:  Pigmentary Retinopathy in Patients Receiving High Doses of a New Phenothiazine ,  Arch Ophthal 64:95-106, 1960.Crossref